Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M7SQ
|
|||
Former ID |
DNC004655
|
|||
Drug Name |
1,1,1-Trifluoro-9-phenyl-nonan-2-one
|
|||
Synonyms |
CHEMBL91417; 1,1,1-trifluoro-9-phenyl-nonan-2-one; SCHEMBL5267943; BDBM50073987
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H19F3O
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCCC(=O)C(F)(F)F
|
|||
InChI |
1S/C15H19F3O/c16-15(17,18)14(19)12-8-3-1-2-5-9-13-10-6-4-7-11-13/h4,6-7,10-11H,1-3,5,8-9,12H2
|
|||
InChIKey |
BAGRIDDIIFOCBK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.